Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Percutaneous Trans-Coronary Venous Mitral Annuloplasty in Patients With Functional Mitral Regurgitation: Analysis of Poznan Carillon Registry Data.

Kałmucki P, Jerzykowska O, Dankowski R, Baszko A, Kramer L, Szyszka A, Siminiak T.

J Interv Cardiol. 2016 Dec;29(6):632-638. doi: 10.1111/joic.12349. Epub 2016 Nov 4.

PMID:
27813186
2.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

3.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

4.

Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry.

Stępińska J, Marona M, Greenlaw N, Steg G; Polish Clarify Investigators.

Kardiol Pol. 2014;72(11):1156-64. doi: 10.5603/KP.a2014.0134. Epub 2014 Jul 8.

5.

B-type natriuretic peptide in patients after percutaneous trans-coronary-sinus mitral annuloplasty.

Siminiak T, Jerzykowska O, Kuzemczak M, Szyszka A, Kałmucki P, Baszko A.

Kardiol Pol. 2014;72(5):446-51. doi: 10.5603/KP.a2014.0017. Epub 2014 Feb 14.

6.

Cardiac resynchronisation therapy after percutaneous trans-coronary-venous mitral annuloplasty.

Siminiak T, Jerzykowska O, Kalmucki P, Link R, Baszko A.

Kardiol Pol. 2013;71(12):1293-4. doi: 10.5603/KP.2013.0326.

7.

Value of rotational angiography (3D-ATG) with contrast agent administration into the right atrium during atrial fibrillation ablation procedures: a preliminary report.

Baszko A, Lanocha M, Kałmucki P, Michalski M, Jerzykowska O, Elikowski W, Kociemba A, Pyda M, Siminiak T, Szyszka A.

Kardiol Pol. 2012;70(9):924-30.

8.

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.

9.

Functional assessment of patients after percutaneous mitral valvuloplasty with Carillon™ device: a preliminary report.

Wołoszyn M, Jerzykowska O, Kałmucki P, Link R, Firek L, Kuzemczak M, Siminiak T.

Kardiol Pol. 2011;69(3):228-33.

10.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

11.

Echocardiographic evaluation of percutaneous valve repair in patients with mitral regurgitation using the CARILLON system.

Jerzykowska O, Kałmucki P, Wołoszyn M, Smuszkiewicz P, Firek L, Siminiak T.

Kardiol Pol. 2010 Jan;68(1):57-63.

12.

Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.

N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31.

13.

Changes in heart rate variability caused by coronary angioplasty depend on the localisation of coronary lesions.

Janowska-Kulińska A, Torzyńska K, Markiewicz-Grochowalska A, Sowińska A, Majewski M, Jerzykowska O, Pawlak-Buś K, Kramer L, Moczko J, Siminiak T.

Kardiol Pol. 2009 Feb;67(2):130-8; discussion 139. English, Polish.

14.

Percutaneous valve repair for mitral regurgitation using the Carillon Mitral Contour System. Description of the method and case report.

Siminiak T, Firek L, Jerzykowska O, Kałmucki P, Wołoszyn M, Smuszkiewicz P, Link R.

Kardiol Pol. 2007 Mar;65(3):272-8; discussion 279.

PMID:
17436155
15.

Bone marrow stem cell imaging after intracoronary administration.

Kurpisz M, Czepczyński R, Grygielska B, Majewski M, Fiszer D, Jerzykowska O, Sowiński J, Siminiak T.

Int J Cardiol. 2007 Oct 1;121(2):194-5. Epub 2006 Nov 13.

PMID:
17101186
16.

Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial.

Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kałmucki P, Kurpisz M.

Eur Heart J. 2005 Jun;26(12):1188-95. Epub 2005 Mar 10.

PMID:
15764613
17.

Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N, Kurpisz M.

Am Heart J. 2004 Sep;148(3):531-7.

PMID:
15389244
18.

[Autologous transplantation of skeletal myoblasts in the treatment of postinfarction left heart dysfunction: three-month follow-up].

Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N, Kałmucki P, Kurpisz M.

Kardiol Pol. 2004 Feb;60 Suppl 1:I-71-6. Polish. No abstract available.

PMID:
15247951
19.

Autologous bone marrow stem cell transplantation in acute myocardial infarction-report of two cases.

Siminiak T, Grygielska B, Jerzykowska O, Fiszer D, Kałmucki P, Rzeźniczak J, Kurpisz M.

Kardiol Pol. 2003 Dec;59(12):502-10. Review.

PMID:
14724697
20.

Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment--report on two cases.

Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Kałmucki P, Kurpisz M.

Kardiol Pol. 2003 Dec;59(12):492-501. Review. English, Polish.

PMID:
14724696

Supplemental Content

Loading ...
Support Center